Trials / Terminated
TerminatedNCT02532543
Comparative Volumetric Assessment of Alveolar Ridge Preservation Utilizing Different Bone Grafting Materials
Prospective, Comparative Volumetric Assessment of Alveolar Ridge Preservation Utilizing Different Bone Grafting Materials (SYMBIOS CORTICAL-CANCELLOUS GRANULE MIX; SYMBIOS OSTEOGRAF LD-300; OSTEOGRAF/N-300) Following Tooth Extraction
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- University of North Carolina, Chapel Hill · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
This study is intended to provide statistically robust evidence that Symbios Demineralized Cortical-cancellous granule mix, Symbios OsteoGraf LD-300, and OsteoGraf/N-300 combined with Symbios OsteoShield Collagen Resorbable Membrane can adequately support the alveolus during ridge augmentation procedures, reducing the dimensional changes of both the alveolus and the overlying soft tissues. Additionally, a comparison between each material will be made, providing further evidence of each materials' ability to preserve the alveolus. It is intended to define in objective terms the response of the hard and soft tissues to ridge augmentation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Allograft, Membrane | Allograft, Membrane- Symbios mineralized cortical-cancellous granule mix, Symbios OsteoShield Collagen Resorbable Membrane |
| BIOLOGICAL | Alloplast, Membrane | Alloplast, Membrane- Symbios OsteoGraf/LD-300, Symbios OsteoShield Collagen Resorbable Membrane |
| BIOLOGICAL | Xenograft, Membrane | Xenograft, Membrane- OsteoGraf/N-300,Symbios OsteoShield Collagen Resorbable Membrane |
| BIOLOGICAL | Membrane | Membrane - Symbios OsteoShield Collagen Resorbable Membrane |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2018-02-12
- Completion
- 2018-02-12
- First posted
- 2015-08-25
- Last updated
- 2019-12-09
- Results posted
- 2019-12-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02532543. Inclusion in this directory is not an endorsement.